Nisa Investment Advisors
LFCR icon

Nisa Investment Advisors’s Lifecore Biomedical LFCR Stock Holding History

Nisa Investment Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22
Closed -$82 – 3142
2026
Q1 		$82 Sell
22
-93
-81% -$642 ﹤0.01% 3015
2025
Q4 		$941 Hold
115
– – ﹤0.01% 2720
2025
Q3 		$846 Hold
115
– – ﹤0.01% 2772
2025
Q2 		$934 Hold
115
– – ﹤0.01% 2747
2025
Q1 		$810 Buy
115
+37
+47% +$230 ﹤0.01% 2690
2024
Q4 		$580 Buy
78
+69
+767% +$441 ﹤0.01% 2798
2024
Q3 		$44 Hold
9
– – ﹤0.01% 2943
2024
Q2 		$46 Sell
9
-19
-68% -$113 ﹤0.01% 2906
2024
Q1 		$149 Hold
28
– – ﹤0.01% 2685
2023
Q4 		$173 Hold
28
– – ﹤0.01% 2576
2023
Q3 		$211 Hold
28
– – ﹤0.01% 2658
2023
Q2 		$271 Buy
+28
New +$171 ﹤0.01% 2673
2023
Q1 		– Sell
-3,630
Closed -$24K – 2610
2022
Q4 		$24K Hold
3,630
– – ﹤0.01% 2012
2022
Q3 		$36K Hold
3,630
– – ﹤0.01% 1866
2022
Q2 		$36K Hold
3,630
– – ﹤0.01% 1851
2022
Q1 		$42K Hold
3,630
– – ﹤0.01% 1891
2021
Q4 		$39K Buy
+3,630
New +$35.2K ﹤0.01% 1793

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Nisa Investment Advisors's LFCR Position: Q2 2026 in Review

Nisa Investment Advisors sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 22 shares — an estimated $82 sold.

Nisa Investment Advisors first reported a position in LFCR in Q4 2021 and held it in 17 quarters. The position peaked at $42K in Q1 2022. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Nisa Investment Advisors reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 22 Lifecore Biomedical shares in Q2 2026, an estimated $82.
  • Nisa Investment Advisors first reported a position in Lifecore Biomedical in Q4 2021 and held it in 17 quarters.
  • Nisa Investment Advisors's Lifecore Biomedical position peaked at $42K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.